Archive for January, 2009

Adverse Event Reporting News - Clinical trials investigator accuses drug companies of delaying release of study results

Saturday, January 10th, 2009

The lead outside investigator on a crucial trial of two widely used heart drugs said in an e-mail message last July that Merck and Schering-Plough, the companies that make the drugs, were deliberately delaying the release of the trial results “to hide something,” The New York Times reported April 1.
The companies did not release the preliminary results of the trial, called Enhance, until January, almost two years after the trial was finished. When they were finally released, t…

Chain Drug Review - Merck’s Zocor gets additional exclusivity

Wednesday, January 7th, 2009

Merck & Co. has received an additional six months of patent protection in the United States for its cholesterol-lowering drug Zocor. The patent, which was due to expire after December 23, 2005, now extends to June 23, 2006. Merck, which achieves annual sales of more than $6 billion with Zocor, is seeking to enhance the Zocor franchise through a partnership with Schering-Plough Corp.

Adverse Event Reporting News - Consumers lawsuits target drug ads

Tuesday, January 6th, 2009

A controversy over the cholesterol-fighting medicine Vytorin has spawned at least 33 lawsuits by consumers who are angry over the way Merck and Schering-Plough promoted the medicine to lower low-density lipoprotein, “The …

Order Lipitor online | Buy Meridia Online | Mexican Pharmacies

Thursday, January 1st, 2009

If you have cholesterol problem and you are continuously ignoring it then it can create serious problems for you. Lipitor which includes pravachol lipitor, lipitor pravachol or lipitor zetia is the best m…